ArticleAmerican journal of cancer research2018

Nedaplatin and paclitaxel compared with carboplatin and paclitaxel for patients with platinum-sensitive recurrent ovarian cancer.

Li Ge et al.PubMed ↗Full text ↗

No numbers read from the abstract.